All In MedTech

Device Trial Radar · NCT01907828

A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence

Last checked: Nov 19, 2026Latest source record: May 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

61

Actual

Start

Apr 15, 2014

Primary completion

Oct 15, 2018

Study completion Oct 15, 2018

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jul 25, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post market clinical investigation is to complete preliminary evaluation on whether or not concomitant renal denervation with the EnligHTN™ Renal Denervation System and cardiac ablation will result in improved outcomes as compared to ablation alone in patients with uncontrolled hypertension being treated for Atrial Fibrillation

Conditions

  • Persistent Atrial Fibrillation
  • Paroxysmal Atrial Fibrillation
  • Hypertension

Interventions

  • Renal Artery AblationDevice

    Renal artery denervation using the EnligHTN™ Renal Denervation System

  • Cardiac AblationDevice

    Safire BLU™ Duo or Therapy Cool Path Duo Irrigated Ablation Catheter or Therapy Cool Flex Irrigated Ablation Catheter EnSite Velocity System Agilis NxT Guiding Introducer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Freedom From Atrial Fibrillation at 12 MonthTime frame: 12 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Herzzentrum Dresden GmbH Universitätsklinik

    Dresden, Germany

  • Herzzentrum Leipzig GmbH

    Leipzig, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.